DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 129 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $58,664,640 | -8.6% | 4,612,000 | +1.1% | 0.90% | -3.2% |
| Q2 2023 | $64,204,800 | +1.4% | 4,560,000 | +11.2% | 0.93% | +1.9% |
| Q1 2023 | $63,345,000 | -25.3% | 4,100,000 | -20.7% | 0.91% | -38.3% |
| Q4 2022 | $84,769,080 | -3.9% | 5,172,000 | +8.5% | 1.48% | -3.3% |
| Q3 2022 | $88,208,000 | +24.2% | 4,768,000 | -11.7% | 1.53% | +23.5% |
| Q2 2022 | $71,010,000 | +31.3% | 5,400,000 | -7.5% | 1.24% | +18.5% |
| Q1 2022 | $54,100,000 | +61.4% | 5,836,000 | +70.1% | 1.05% | +90.9% |
| Q4 2021 | $33,513,000 | +45.5% | 3,430,154 | +405.9% | 0.55% | +40.5% |
| Q3 2021 | $23,038,000 | +33.3% | 678,000 | +43.6% | 0.39% | +26.2% |
| Q2 2021 | $17,280,000 | – | 472,000 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |